Key term: carcinogen

Original article 2025;51(2):100-110   pdf full text
Occupational exposures of firefighting and prostate cancer risk in the Norwegian Fire Departments Cohort
Marjerrison N, Grimsrud TK, Hansen J, Martinsen JI, Nordby K-C, Olsen R, Stenehjem JS, Veierød MB, Kjærheim K
 
Original article 2022;48(3):210-219   pdf full text
Cancer incidence in sites potentially related to occupational exposures: 58 years of follow-up of firefighters in the Norwegian Fire Departments Cohort
Marjerrison N, Jakobsen J, Grimsrud TK, Hansen J, Martinsen JI, Nordby K-C, Veierød MB, Kjærheim K
 
Original article 2020;46(3):278-292   pdf full text
Predicting residential radon concentrations in Finland: Model development, validation, and application to childhood leukemia
Nikkilä A, Arvela H, Mehtonen J, Raitanen J, Heinäniemi M, Lohi O, Auvinen A
 
Letter to the Editor 2020;46(1):110-112   pdf full text
A silent epidemic: occupational exposure limits are insufficiently protecting individual worker health
Albin M, Gustavsson P
 
Letter to the Editor 2019;45(4):423-424   pdf full text
Binding occupational exposure limits for carcinogens in the EU – necessary but not sufficient to reduce risk
Cherrie JW
 
Editorial 2019;45(3):213-214   pdf full text
Binding occupational exposure limits for carcinogens in the EU – good or bad?
Johanson G, Tinnerberg H
 
Review 2012;38(6):503-515   pdf
Unrecognized risks of nickel-related respiratory cancer among Canadian electrolysis workers
Grimsrud TK, Andersen A
 
Letter to the Editor 1981;7(3):237-238   pdf
Re: "Mutagenic action of isocyanates used in the production of polyurethanes" by MAnderson, M-L Binderup, P Kiel, H Larson, J MalCiid. Scand J Work Environ Health 6 (1980) 221-226
Diller WF
 
Original article 1980;6(3):221-226   pdf
Mutagenic action of isocyanates used in the production of polyurethanes.
Andersen M, Binderup M-L, Kiel P, Larsen H, Maxild J
 
Original article 1980;6(4):299-301   pdf
Increased sister chromatid exchange frequencies in lymphocytes of nurses handling cytostatic drugs.
Norppa H, Sorsa M, Vainio H, Gröhn P, Heinonen E, Holsti L, Nordman E
  1  2  (show all)